|
 |
|
US Home/Self Testing Diagnostics Market: Diabetes, Pregnancy, Ovulation, Occult Blood -- Business Challenges and Marketing Strategies for Suppliers
This new 175-page report from VPGMarketResearch.com provides analysis of the�major home/self testing market segments, including diabetes (strips and meters), pregnancy, ovulation, and occult blood....
|
 |
|
$1450.00 |
| |
|
|
|
Home/Self Testing Diagnostics Market
This new 175-page report from VPGMarketResearch.com provides analysis of the major home/self testing market segments, including diabetes (strips and meters), pregnancy, ovulation, and occult blood....
|
|
|
$1450.00 |
| |
|
|
|
Carbamazepine: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketReserach.com provides analysis of Carbamazepine testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Amikacin: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Amikacin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Albumin: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of Albumin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Alkaline Phosphatase: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of Alkaline Phosphatase testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
ALT/SGPT: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of ALT/GPT testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Ammonia: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of Ammonia testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Amylase: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of Amylase testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
AST/SGOT: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of AST/SGOT testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Bilirubin: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of Bilirubin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
BUN (Blood Urea Nitrogen): 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of BUN (Blood Urea Nitrogen)testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Calcium: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of Calcium testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Carbon Dioxide/Bicarbonate: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of Carbon Dioxide/Bicarbonate testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Chloride: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of Chloride testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Cholesterol: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of Cholesterol testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Creatine Kinase (CK): 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of Creatine Kinase (CK) testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
CK-MB: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of CK-MB testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
|